Total, Bioavailable, and Free 25(OH)D Relationship with Indices of Bone Health in Elderly: A Randomized Controlled Trial.

Abstract

CONTEXT:

Questions regarding the superiority of free and bioavailable 25-hydroxyvitamin D [25(OH)D] in predicting health outcomes remain unresolved.

OBJECTIVE:

This study investigates the impact of vitamin D variables-total, bioavailable, or free 25(OH)D-on indices of bone and mineral metabolism, at baseline and in response to 2 vitamin D doses.

DESIGN:

Our objectives are implemented as exploratory analyses on data collected in a 1-year, double-blind, randomized controlled trial completed in July 2014.

SETTING:

Participants were recruited from 3 major hospitals in an ambulatory setting.

PARTICIPANTS:

Participants were >65 years of age, overweight, and had a baseline serum 25(OH)D between 10 and 30 ng/mL. A total of 221 participants completed the study.

INTERVENTION:

Subjects were randomized to receive calcium and oral vitamin D3 (600 IU/day or 3750 IU/day) supplementation.

RESULTS:

Participants who received the higher vitamin D dose had levels that were 1.3- to 1.4-fold higher than those taking the lower dose, for all variables (P value < 0.001). Serum values of bioavailable and free 25(OH)D were associated with total 25(OH)D, with r values of 0.942 and 0.943, respectively (P value < 0.001). Parathyroid hormone (PTH) was negatively associated with all vitamin D variables, with correlation coefficients ranging from -0.22 to -0.25, while calcium and bone turnover markers (carboxy-terminal collagen crosslinks and osteocalcin) did not. Only total 25(OH)D had a positive relationship with % change bone mineral density (BMD) at the femoral neck at 12 months, while only free and bioavailable 25(OH) had a positive relationship with % change total body BMD at 12 months.

CONCLUSION:

Calculated free and bioavailable 25(OH)D do not appear to be superior to total 25(OH)D in predicting indices of bone health in an elderly population.

• Authors: Malak El Sabeh, Paola Ghanem, Laila Al-Shaar, Maya Rahme, Rafic Baddoura, Georges Halaby, Ravinder J Singh, Dirk Vanderschueren, Roger Bouillon, Ghada El-Hajj Fuleihan
• Journal: The Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab) Vol. 106 Issue 2 Pg. e990-e1001 (01 23 2021) ISSN: 1945-7197 [Electronic] United States
• PMID: 33280041 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
• Copyright: © The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: [email protected].

Chemical References

• Biomarkers
• Vitamins
• Vitamin D
• 25-hydroxyvitamin D

Topics

• Aged
• Biomarkers (blood)
• Bone Density
• Double-Blind Method
• Female
• Follow-Up Studies
• Humans
• Male
• Prognosis
• Vitamin D (analogs & derivatives, blood)
• Vitamins (blood)